• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病认知筛查表现与运动症状之间的关联:一项系统综述和荟萃分析。

Associations between cognitive screening performance and motor symptoms in Parkinson's disease:a systematic review and meta-analysis.

作者信息

Patrick Karlee, Cousins Elizabeth, Spitznagel Mary Beth

机构信息

Kent State University, College of Arts and Sciences, Department of Psychological Sciences, Kent, Ohio, USA.

出版信息

Dement Neuropsychol. 2024 Sep 2;18:e20230102. doi: 10.1590/1980-5764-DN-2023-0102. eCollection 2024.

DOI:10.1590/1980-5764-DN-2023-0102
PMID:39258165
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11386525/
Abstract

UNLABELLED

Although the most prominent symptoms of Parkinson's disease (PD) are those impacting movement, cognitive dysfunction is prevalent and often presents early in the disease process. Individuals with cognitive symptoms of PD often complete cognitive screening, making it important to identify factors associated with cognitive screening performance to ensure prompt and accurate detection of cognitive impairments.

OBJECTIVE

Despite a body of research examining relationships between motor symptoms and cognitive dysfunction in PD, no prior study has undertaken a systematic review of the magnitude of the relationship between motor symptoms and cognitive screening performance in PD.

METHODS

This study was a systematic review and meta-analysis of the relationship between cognitive screening performance, as assessed by the Montreal Cognitive Assessment (MoCA), and motor symptoms of PD. After the systematic screening, 20 studies were included, and meta-regressions using mixed-effects models were conducted.

RESULTS

Motor symptoms across included studies were relatively mild, but average MoCA scores were at the established cutoff for risk of dementia in PD. The average disease duration was 5 years. Consistent with hypotheses, more severe motor symptoms were associated with lower MoCA scores (-0.22 (95%CI -0.29 to -0.16), p<0.001), indicating worse cognitive functioning.

CONCLUSION

The results indicate a significant negative correlation between MoCA performance and motor symptoms of PD. Average MoCA scores captured early disease-stage cognitive impairment when motor symptoms remained relatively mild. Serial screening for cognitive impairment beginning early in the disease course may be of benefit to ensure that cognitive dysfunction is detected as it arises.

摘要

未标注

尽管帕金森病(PD)最突出的症状是影响运动的症状,但认知功能障碍很普遍,且常在疾病过程早期出现。有PD认知症状的个体常进行认知筛查,因此识别与认知筛查表现相关的因素对于确保及时准确地检测认知障碍很重要。

目的

尽管有大量研究探讨了PD运动症状与认知功能障碍之间的关系,但此前尚无研究对PD运动症状与认知筛查表现之间关系的程度进行系统综述。

方法

本研究是对通过蒙特利尔认知评估(MoCA)评估的认知筛查表现与PD运动症状之间关系的系统综述和荟萃分析。经过系统筛选,纳入了20项研究,并使用混合效应模型进行了荟萃回归分析。

结果

纳入研究中的运动症状相对较轻,但MoCA平均得分处于PD痴呆风险的既定临界值。平均病程为5年。与假设一致,更严重的运动症状与更低的MoCA得分相关(-0.22(95%CI -0.29至-0.16),p<0.001),表明认知功能更差。

结论

结果表明MoCA表现与PD运动症状之间存在显著负相关。当运动症状仍相对较轻时,MoCA平均得分反映了疾病早期阶段的认知障碍。在疾病进程早期开始对认知障碍进行系列筛查可能有助于确保在认知功能障碍出现时就被检测到。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/800f/11386525/75f745c88d9b/1980-5764-DN-18-e20230102-gf3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/800f/11386525/bafc45b9bd6a/1980-5764-DN-18-e20230102-gf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/800f/11386525/986c1056e48c/1980-5764-DN-18-e20230102-gf2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/800f/11386525/75f745c88d9b/1980-5764-DN-18-e20230102-gf3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/800f/11386525/bafc45b9bd6a/1980-5764-DN-18-e20230102-gf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/800f/11386525/986c1056e48c/1980-5764-DN-18-e20230102-gf2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/800f/11386525/75f745c88d9b/1980-5764-DN-18-e20230102-gf3.jpg

相似文献

1
Associations between cognitive screening performance and motor symptoms in Parkinson's disease:a systematic review and meta-analysis.帕金森病认知筛查表现与运动症状之间的关联:一项系统综述和荟萃分析。
Dement Neuropsychol. 2024 Sep 2;18:e20230102. doi: 10.1590/1980-5764-DN-2023-0102. eCollection 2024.
2
Clinical variables and biomarkers in prediction of cognitive impairment in patients with newly diagnosed Parkinson's disease: a cohort study.临床变量和生物标志物在新诊断帕金森病患者认知障碍预测中的作用:一项队列研究
Lancet Neurol. 2017 Jan;16(1):66-75. doi: 10.1016/S1474-4422(16)30328-3. Epub 2016 Nov 18.
3
Comparison of Mini-Mental State Examination and Montreal Cognitive Assessment Ratings Across Levels of Parkinson's Disease Severity.帕金森病严重程度不同水平下简易精神状态检查表与蒙特利尔认知评估量表评分的比较
J Parkinsons Dis. 2021;11(4):1995-2003. doi: 10.3233/JPD-212705.
4
Screening for Cognitive Impairment in Movement Disorders: Comparison of the Montreal Cognitive Assessment and Quick Mild Cognitive Impairment Screen in Parkinson's Disease and Lewy Body Dementia.运动障碍中认知障碍的筛查:帕金森病和路易体痴呆中蒙特利尔认知评估与快速轻度认知障碍筛查的比较
J Alzheimers Dis Rep. 2024 Jun 21;8(1):971-980. doi: 10.3233/ADR-230207. eCollection 2024.
5
Apolipoprotein Eε4: A Biomarker for Executive Dysfunction among Parkinson's Disease Patients with Mild Cognitive Impairment.载脂蛋白Eε4:轻度认知障碍帕金森病患者执行功能障碍的生物标志物。
Front Neurosci. 2017 Dec 20;11:712. doi: 10.3389/fnins.2017.00712. eCollection 2017.
6
Test the Best: Classification Accuracies of Four Cognitive Rating Scales for Parkinson's Disease Mild Cognitive Impairment.最佳测试:帕金森病轻度认知障碍四种认知评定量表的分类准确性
Arch Clin Neuropsychol. 2020 Oct 8;35(7):1069–1077. doi: 10.1093/arclin/acaa039. Epub 2020 Jul 17.
7
Validity and reliability of the Persian version of the Montreal Cognitive Assessment (MoCA-P) scale among subjects with Parkinson's disease.帕金森病患者中蒙特利尔认知评估量表(MoCA-P)波斯语版本的有效性和可靠性。
Appl Neuropsychol Adult. 2020 Sep-Oct;27(5):431-439. doi: 10.1080/23279095.2019.1565762. Epub 2019 Mar 1.
8
9
Using the Montreal Cognitive Assessment Scale to screen for dementia in Chinese patients with Parkinson's Disease.使用蒙特利尔认知评估量表对中国帕金森病患者进行痴呆筛查。
Shanghai Arch Psychiatry. 2013 Oct;25(5):296-305. doi: 10.3969/j.issn.1002-0829.2013.05.005.
10
Predictors of cognitive impairment in an early stage Parkinson's disease cohort.帕金森病早期队列认知障碍的预测因素。
Mov Disord. 2014 Mar;29(3):351-9. doi: 10.1002/mds.25748. Epub 2014 Jan 6.

本文引用的文献

1
Clinimetrics and feasibility of the Italian version of the Frontal Assessment Battery (FAB) in non-demented Parkinson's disease patients.非痴呆型帕金森病患者中 Frontal Assessment Battery(FAB)意大利版的临床计量学和可行性。
J Neural Transm (Vienna). 2023 May;130(5):687-696. doi: 10.1007/s00702-023-02624-7. Epub 2023 Mar 28.
2
Predictors of cognitive impairment in newly diagnosed Parkinson's disease with normal cognition at baseline: A 5-year cohort study.基线认知功能正常的新诊断帕金森病患者认知障碍的预测因素:一项5年队列研究。
Front Aging Neurosci. 2023 Feb 28;15:1142558. doi: 10.3389/fnagi.2023.1142558. eCollection 2023.
3
Low serum uric acid levels and levodopa-induced dyskinesia in Parkinson's disease.
帕金森病患者血清尿酸水平降低与左旋多巴诱导的运动障碍。
Arq Neuropsiquiatr. 2023 Jan;81(1):40-46. doi: 10.1055/s-0043-1761294. Epub 2023 Mar 14.
4
The pathobiological basis of depression in Parkinson disease: challenges and outlooks.帕金森病中抑郁的病理生物学基础:挑战与展望。
J Neural Transm (Vienna). 2022 Dec;129(12):1397-1418. doi: 10.1007/s00702-022-02559-5. Epub 2022 Nov 2.
5
Associations of cognitive dysfunction with motor and non-motor symptoms in patients with de novo Parkinson's disease.新发帕金森病患者认知功能障碍与运动及非运动症状的相关性研究。
Sci Rep. 2022 Jul 6;12(1):11461. doi: 10.1038/s41598-022-15630-8.
6
Sex Differences in Brain and Cognition in Parkinson's Disease.帕金森病中大脑与认知的性别差异
Front Aging Neurosci. 2022 Jan 6;13:791532. doi: 10.3389/fnagi.2021.791532. eCollection 2021.
7
Cognitive Impairment in Genetic Parkinson's Disease.遗传性帕金森病中的认知障碍
Parkinsons Dis. 2021 Dec 30;2021:8610285. doi: 10.1155/2021/8610285. eCollection 2021.
8
Global Trends in the Incidence, Prevalence, and Years Lived With Disability of Parkinson's Disease in 204 Countries/Territories From 1990 to 2019.2019 年全球 204 个国家和地区帕金森病发病率、患病率和伤残调整生命年的变化趋势
Front Public Health. 2021 Dec 7;9:776847. doi: 10.3389/fpubh.2021.776847. eCollection 2021.
9
Cognition, motor symptoms, and glycolipid metabolism in Parkinson's disease with depressive symptoms.帕金森病伴抑郁患者的认知、运动症状和糖脂代谢。
J Neural Transm (Vienna). 2022 Jun;129(5-6):563-573. doi: 10.1007/s00702-021-02437-6. Epub 2021 Nov 27.
10
Pain coping strategies and their association with quality of life in people with Parkinson's disease: A cross-sectional study.帕金森病患者的疼痛应对策略及其与生活质量的关系:一项横断面研究。
PLoS One. 2021 Nov 1;16(11):e0257966. doi: 10.1371/journal.pone.0257966. eCollection 2021.